3 not yet recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Not yet recruiting 3 |
Follow Arteritis: new trials by email Literature Review of Arteritis trials Research Report on Arteritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis Vanakizumab, Ivarmacitinib, Prednisone - Takayasu Arteritis (TAK) | Phase 4 | Not yet recruiting | Chinese SLE Treatment And Research Group | 180 | 2026-04-01 | 2026-03-05 |
| Effect of Pirfenidone on TA Fibrosis Pirfenidone Capsules, Placebo - Takayasu Arteritis | Phase 4 | Not yet recruiting | Shanghai Zhongshan Hospital | 92 | 2025-12-20 | 2026-01-08 |
| The Efficacy and Safety of Deucravacitinib in Takayasu's Arteritis Deucravacitinib, Adalimumab - Takayasu Arteritis (TAK) | Phase 4 | Not yet recruiting | Chinese SLE Treatment And Research Group | 50 | 2025-06-15 | 2025-06-10 |
Takayasu Arteritis (3) · Fibrosis (1) · Inflammation (1) · Recurrence (1)
Aortic Arch Syndromes (3) · Aortic Diseases (3) · Cardiovascular Diseases (3) · Skin Diseases (3) · Skin Diseases, Vascular (3) · Skin and Connective Tissue Diseases (3) · Vascular Diseases (3) · Vasculitis (3) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Disease Attributes (1)
Adalimumab (1) · Prednisone (1) · deucravacitinib (1) · ivarmacitinib (1) · pirfenidone (1)
Chinese SLE Treatment And Research Group (2) · Shanghai Zhongshan Hospital (1)
China (2)
Xinping Tian, MD (1)